These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 2517077

  • 1. Fibrinolytic activity in coronary heart disease.
    Yao SK, Chen ZJ, Tao SQ.
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [Abstract] [Full Text] [Related]

  • 2. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, Fortmann SP, Quertermous T, Hlatky MA, Atherosclerotic Disease, Vascular Function and Genetic Epidemiology Advance (ADVANCE) Study.
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [Abstract] [Full Text] [Related]

  • 3. [Fibrinolytic activity and coronary heart disease].
    Yao SK, Chen ZJ, Tao SQ.
    Zhonghua Nei Ke Za Zhi; 1987 Feb; 26(2):71-3, 124. PubMed ID: 3608720
    [No Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B, Somani PN, Tripathi GK, Dube RK, Bhattacharya SK.
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA, Ignashenkova GV, Kitaev MI.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987 Dec; 10(1):18-21. PubMed ID: 3300697
    [Abstract] [Full Text] [Related]

  • 11. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979 Dec; 7(1):49-52. PubMed ID: 550980
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA, Cornudella R, Gálvez M, Angós JA, Romero S, Gutiérrez M.
    Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
    [Abstract] [Full Text] [Related]

  • 13. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA, Diukov IV, Borodkin VV.
    Ter Arkh; 1986 Feb; 58(12):62-7. PubMed ID: 3824217
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT, Volkov VI, Topchiĭ II, Dykun IaV, Shuliak LN.
    Ter Arkh; 1990 Feb; 62(11):87-90. PubMed ID: 2095000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.